The resolution recognizes November 2025 as COPD Awareness Month in California and commends community organizations and state agencies for their work on prevention, treatment, and public education. It sets out a series of factual findings about COPD’s prevalence, risk factors, and costs, and asks the Assembly’s Chief Clerk to transmit copies of the resolution for distribution.
This is a ceremonial, nonbinding measure: it does not create programs, appropriate funds, or impose legal obligations. Its practical value is political and communicative — it elevates COPD on the state’s policy radar and gives public‑health actors a legislative reference point for outreach and awareness campaigns.
At a Glance
What It Does
The resolution formally recognizes November 2025 as COPD Awareness Month in California, records a set of factual findings about the disease, and commends relevant community organizations and agencies. It directs the Chief Clerk of the Assembly to transmit copies of the resolution to the author for distribution.
Who It Affects
Directly affected parties are primarily non‑regulatory: state and local public health departments, community health organizations, patient advocacy groups, clinicians who treat COPD, and people living with the disease in California. The resolution does not impose regulatory requirements on insurers, employers, or providers.
Why It Matters
Although nonbinding, the resolution signals legislative attention to COPD’s health and financial impact and can be used by agencies and nonprofits to justify outreach, fundraising, and program visibility. It creates no entitlements or funding but may shape policy conversations and public messaging.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The body of the resolution begins with a series of WHEREAS clauses that assemble statistics and background about chronic obstructive pulmonary disease: how COPD affects airflow, its prevalence, its status as a leading cause of disability and death, various risk factors (including smoking and environmental exposures), and populations at higher risk. The clauses also cite medical‑cost figures and projections to frame COPD as a costly public‑health problem.
After the findings, the resolution contains two Resolved clauses. The first formally recognizes November 2025 as COPD Awareness Month in California and commends the work of community organizations and state agencies that conduct prevention, education, and support services.
The second directs the Assembly’s Chief Clerk to transmit copies of the resolution to the author for distribution — a standard administrative step to enable circulation of the resolution text to stakeholders.Legally, the resolution is declaratory and symbolic. It does not appropriate funds, change statutes or regulations, create new duties for agencies, or authorize programs.
Practically, that means its main effects are rhetorical and facilitative: public‑health bodies and nonprofits can cite the resolution in outreach materials and grant applications, local governments may schedule events around the designated month, and advocates may use the legislative language to press for more substantive measures in the future.
The Five Things You Need to Know
The resolution formally designates November 2025 as COPD Awareness Month in California and commends community organizations and agencies for their COPD programs and awareness efforts.
It cites an estimated 30,000,000 Americans affected by COPD and states that only 17,000,000 of those are diagnosed.
The resolution reports a 2021 prevalence of COPD of 5.6 percent among insured individuals in California.
It records cost figures cited in the text: $2,000,450,000 in 2019 medical treatment costs in California for Medicare, Medicaid, and private insurance, and a projected cost attributable to COPD in 2029 of $60,500,000,000.
The only procedural requirement is administrative: the Chief Clerk must transmit copies of the resolution to the author for appropriate distribution; the measure contains no funding, mandates, or regulatory changes.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings: prevalence, risk factors, and cost
The preamble compiles factual statements about COPD — disease description, prevalence estimates, mortality and disability rankings, risk factors (smoking, environmental exposures, genetic alpha‑1 antitrypsin deficiency, childhood respiratory history), and cost estimates. For practical purposes, these findings are evidence the Assembly is using to justify recognition; they do not create legal obligations but may be cited in later policy proposals or grant applications.
Designation and commendation
This clause declares November 2025 as COPD Awareness Month in California and commends the contributions of community organizations and agencies. The operative effect is symbolic recognition: it publicly acknowledges work on COPD outreach and gives visibility to advocacy and service providers without directing policy change or resources.
Administrative transmission
The second clause instructs the Chief Clerk of the Assembly to transmit copies of the resolution to the author for distribution. This is a routine administrative provision intended to distribute the resolution text to stakeholders; it imposes only minor clerical work and does not authorize follow‑up action by state agencies.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People with COPD and their families — the designation raises public awareness and can reduce stigma, helping connect individuals to screening, treatment, and support resources.
- Community health organizations and patient advocacy groups — the resolution provides a legislative reference they can cite in outreach materials, fundraising appeals, and program promotion.
- State and local public health departments — they gain a formal recognition to anchor outreach campaigns and coordinate local events during November without needing new legislation.
- Clinicians and respiratory therapists — increased public awareness may lead to earlier diagnosis and referrals, potentially improving patient outcomes and demand for clinical services.
Who Bears the Cost
- Assembly administrative staff (Chief Clerk) — minimal clerical time to reproduce and distribute copies of the resolution.
- Local public health departments and nonprofits — if they choose to mount events or campaigns in response to the designation, they will absorb planning and outreach costs from existing budgets.
- Advocacy organizations — while benefiting from increased visibility, these groups may feel pressure to scale up services or communications during the designated month, incurring opportunity costs.
- No state agencies or insurers bear direct legal or fiscal obligations under the resolution — any costs arise only if stakeholders decide to act on the recognition.
Key Issues
The Core Tension
The central tension is symbolic recognition versus substantive remediation: the Assembly signals the importance of COPD through formal recognition, but it stops short of committing resources or regulatory changes that would address access, diagnosis, and treatment gaps — leaving stakeholders to convert attention into action without guaranteed support.
The resolution trades limited legal effect for symbolic weight. Its only enforceable instruction is an administrative transmission to the Chief Clerk; it does not appropriate funds, create programs, or change regulatory authority.
That limits its immediate capacity to change health outcomes — awareness alone does not expand access to diagnostics, inhalers, pulmonary rehabilitation, or long‑term case management.
The bill also assembles a mix of California‑specific and broader figures without providing source detail within the text; that can create ambiguity about the geographic scope of some statistics and how readers should interpret the cost projections. Finally, because the resolution is voluntary and nonbinding, uptake will be uneven: localities with robust public‑health infrastructure can leverage the designation, while underresourced rural or low‑income communities identified as higher risk may not see commensurate outreach or resources.
Measuring the impact of an awareness month is another unresolved issue. The resolution contains no metrics, reporting requirements, or funding to evaluate whether outreach reduces undiagnosed cases or improves treatment access.
That leaves the work of converting symbolic recognition into measurable health gains to agencies and nonprofits that must do so within their existing budgets and priorities.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.